U.S. Integrated Operating Rooms Market Size to Surpass USD 8.34 Bn by 2032
The U.S. integrated operating rooms market size was estimated at USD 3.16 billion in 2022 and is expected to surpass around USD 8.34 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 10.2% during the forecast period 2023 to 2032.
Key Takeaways:
U.S. Integrated Operating Rooms Market Report Scope
| Report Attribute | Details |
| Market Size in 2023 | USD 3.48 Billion |
| Market Size by 2032 | USD 8.34 Billion |
| Growth Rate From 2023 to 2032 | CAGR of 10.2% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | End-Use |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Stryker; Brainlab AG; Barco; Steris Plc; Arthrex, Inc.; Karl Storz; Olympus Corp.; Getinge AB; Skytron, LLC; Caresyntax; Sony |
The key factors driving the market growth include the rising number of Ambulatory Surgery Centers (ASCs), technologically advanced healthcare IT infrastructure, the growing popularity of integrated ORs, and increasing demand for minimally invasive & image-guided procedures.
For nearly 18 months during the pandemic, both physicians and patients made decisions to defer many forms of surgery, whenever possible. As more patients feel confident regarding considering surgery, demand to schedule procedures at all types of hospitals and surgery centers has increased over the recent months. Thus, impacting the market growth. In 2020, the COVID-19 pandemic had a substantial impact on the hospitals across the U.S. In total, the country saw a 35% reduction in surgical volume from March to July 2020, contributing to a loss of over USD 200 billion.
The U.S. medical industry depends heavily upon revenue generated by surgical procedures. Investments in the most up-to-date equipment and technology are a priority for hospitals to remain competitive. Presently, these ORs comprise fully integrated systems that are fixed. Traditional ORs help deal with video signals created by the imaging system. An integrated OR needs several other modalities, which are used with the imaging system and consequently require more advanced integration machinery. Moreover, various strategic initiatives being undertaken and the presence of well-established players, such as Stryker, STERIS, Olympus, and Skytron, are expected to fuel the growth of the market during the forecast period.
Market players are investing in many strategic initiatives, such as acquisitions, mergers, partnerships, and product launches, to maintain a competitive edge. For instance, in March 2021, Brainlab announced acquiring Mint Medical GmbH. This move provides evidence to the company’s focus on digital health and to advance in the fields of structured diagnosis, analysis, and treatment of cancer and other illnesses to address the demand for modern medication and personalized treatments.
End-use Insights
The ASCs segment is expected to register the fastest growth rate of over 39% from 2023 to 2032 owing to the high demand for ASCs in the U.S. Furthermore, the lack of economic resources and shortage of beds in hospitals is anticipated to boost the growth of this segment during the forecast period.
The Office-based Labs (OBL/physician clinic) segment accounted for a significant revenue share of the global market in 2022. The segment growth is attributed to the increasing patient population suffering from chronic diseases, which is driving the need for integration of operating rooms as it assists in reducing the complexity and burden on physicians for efficient management of surgical workflows.
Key Companies & Market Share Insights
The market is highly competitive and fragmented. Market players implement strategic initiatives, such as product development &launches, expansion of distribution network, and global footprint through subsidiaries and partnerships. Key players are also involved in portfolio diversification and mergers & acquisition. For instance, in January 2021, Stryker publicized the acquisition of OrthoSensor, Inc., a frontrunner in the digital evolution for total joint replacement. This move is expected to strengthen its market position. Some of the key players in the U.S. integrated operating rooms market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Integrated Operating Rooms market.
By End-use
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.1.1 End-use
1.1.2 Estimates and forecast timeline
1.2 Research methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 Nova one advisor’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 U.S. Integrated Operating Rooms Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Technology Trends
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing demand for minimally invasive and image-guided procedures
3.3.1.2 Growing popularity of integrated ORs
3.3.1.3 Technologically advanced healthcare IT infrastructure
3.3.1.4 Rising number of ambulatory surgery centers
3.3.2 Market restraint analysis
3.3.2.1 High cost associated with integrated operating rooms
3.3.3 Market Opportunity Analysis
3.3.3.1 Increasing investments by stakeholders
3.3.4 Market Challenges Analysis
3.3.4.1 Cyber security threats
3.4 U.S. Integrated Operating Rooms: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Bargaining power of buyers:
3.4.1.2 Bargaining power of suppliers:
3.4.1.3 Competitive rivalry:
3.4.1.4 Threat of new entrants:
3.4.1.5 Threat of substitutes:
3.4.2 SWOT by PESTLE analysis
3.4.2.1 Political landscape
3.4.2.2 Environmental landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal landscape
3.4.2.6 Economic landscape
Chapter 4 Impact of COVID-19 on U.S. Integrated Operating Rooms Market
4.1 Disease Prevalence Analysis
4.2 Demand Analysis
4.3 Recent Developments & Strategic Outcomes
Chapter 5 U.S. Integrated Operating Rooms Market: End-use Estimates and Forecasts to 2032
5.1 Definition and Scope
5.2 End-Use Market Share Analysis, 2023 & 2032
5.3 Segment Dashboard
5.4 U.S. Integrated Operating Rooms Market, by End-use, 2020 to 2032
5.5 Market Size & Forecasts and Trend Analyses, 2020 to 2032
5.5.1 Hospitals
5.5.1.1 Hospitals market, 2020 - 2032
5.5.2 Ambulatory Surgical Centers
5.5.2.1 Ambulatory Surgical Centers market, 2020 - 2032
5.5.3 Hospital-based Outpatient Department (HOPD)
5.5.3.1 Hospital-based Outpatient Department (HOPD) market, 2020 - 2032
5.5.4 Office-based Labs (OBLs)
5.5.4.1 Office-based Labs (OBLs) market, 2020 - 2032
Chapter 6 U.S. Integrated Operating Rooms Market: Competitive Analysis
6.1 Recent Developments & Impact Analysis
6.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.2.1 Public Companies
6.2.1.1 Estimated Company Market Share Analysis (2023, %)
6.2.1.2 Major Deals & Strategic Alliances Analysis
6.2.2 Exhaustive List of Players
6.2.3 Detailed List of Integrated Operating Rooms Market Participants
6.2.4 Detailed List of Video Over IP Market Participants
6.2.5 Detailed List of Surgical Display Market Participants
6.2.6 Detailed List of Surgical Teleconferencing Market Participants
6.2.7 Detailed List of Surgical in Wall Consoles Market Participants
Chapter 7 Company Profiles
7.1 Stryker
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Brainlab AG
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Barco
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Steris Plc
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Arthrex, Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 Karl Storz
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Olympus Corporation
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Getinge AB
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Skytron, LLC
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Caresyntax
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
7.11 Sony
7.11.1 Company Overview
7.11.2 Financial Performance
7.11.3 Product Benchmarking
7.11.4 Strategic Initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers